2023
Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study
Price S, Palmer A, Fucito L, Graboyes E, Baker N, Rojewski A, Toll B. Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study. Cancer 2023, 129: 2385-2394. PMID: 37211959, PMCID: PMC10593116, DOI: 10.1002/cncr.34746.Peer-Reviewed Original ResearchConceptsSymptom burdenCurrent smokingCigarette smokingQuit attemptsTobacco useGreater fatiguePast-year quit attemptsCancer symptom burdenUS Population AssessmentCurrent cigarette smokingGreater symptom burdenTobacco treatment interventionsAdult cancer survivorsQuality of lifeSmoking quit attemptEmotional problemsRace/ethnicityCancer survivorsTobacco cessationHealth StudySmokingTreatment interventionsUS FoodMultivariate analysisSurvivors' interestA Secondary Analysis of a Preliminary Contingency Management Intervention for Presurgical Cancer Patients: Evaluating Individual Participant Data
Sanford B, Toll B, Fucito L, Baker N, Krishnan-Sarin S, Carpenter M, Bernstein S, Rojewski A. A Secondary Analysis of a Preliminary Contingency Management Intervention for Presurgical Cancer Patients: Evaluating Individual Participant Data. Nicotine & Tobacco Research 2023, 25: 1614-1618. PMID: 37156634, PMCID: PMC10439489, DOI: 10.1093/ntr/ntad071.Peer-Reviewed Original ResearchMeSH KeywordsCarbon MonoxideHumansMotivationNeoplasmsRecurrenceSmoking CessationTobacco Use Cessation DevicesConceptsContingency management interventionSustained abstinenceMonetary reinforcersMO participantsBehavior patternsManagement interventionsSuccessful abstinenceIndividual behavior patternsSchedule of reinforcementIndividual participantsSecondary analysisAbstinenceEffect sizeEveryday smokersParticipantsFinancial reinforcementVerified abstinenceCM interventionReinforcersCancer patientsInterventionBreath COCM groupExact testLapse
2022
Urgent Need for Novel Investigations of Treatments to Quit E-cigarettes: Findings from a Systematic Review
Palmer AM, Price SN, Foster MG, Sanford BT, Fucito LM, Toll BA. Urgent Need for Novel Investigations of Treatments to Quit E-cigarettes: Findings from a Systematic Review. Cancer Prevention Research 2022, 15: 569-580. PMID: 35816038, PMCID: PMC9444997, DOI: 10.1158/1940-6207.capr-22-0172.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCigarette SmokingElectronic Nicotine Delivery SystemsHumansSmoking CessationTobacco ProductsVapingConceptsE-cigarette cessationE-cigarettesSystematic reviewE-cigarette useSymptoms of dependenceCohort studyCigarette smokingPsychologic factorsQuit attemptsHealth concernCessationCold turkeySmokingLack of satisfactionHigher intentFuture studiesAdultsInterventionAdult samplesUrgent needLack of informationReviewSymptomsAbstinenceIndividualsHarm reduction for smokers with little to no quit interest: can tobacco policies encourage switching to e-cigarettes?
Buckell J, Fucito LM, Krishnan-Sarin S, O'Malley S, Sindelar JL. Harm reduction for smokers with little to no quit interest: can tobacco policies encourage switching to e-cigarettes? Tobacco Control 2022, 32: e173-e179. PMID: 35046127, PMCID: PMC9347898, DOI: 10.1136/tobaccocontrol-2021-057024.Peer-Reviewed Original ResearchMeSH KeywordsAdultElectronic Nicotine Delivery SystemsHarm ReductionHumansSmokersSmoking CessationTobacco ControlTobacco ProductsConceptsGroup choicePolicy-relevant attributesDiscrete choice experimentPreference heterogeneityChoice experimentLatent classesCigarettes/e-cigarettesPolicy concernsLatent variable modelPolicyMenthol cigarette banVariable modelE-cigarettesOwn cigarettesQuit interestStrong preferenceCigarette banChoiceLittle interestLow interestHarm reductionTaxesSevere health consequencesAdult smokersLess harm
2021
Preoperative contingency management intervention for smoking abstinence in cancer patients: trial protocol for a multisite randomised controlled trial
Rojewski AM, Fucito LM, Baker NL, Palmer AM, Foster MG, Warren GW, Bernstein SL, Toll BA. Preoperative contingency management intervention for smoking abstinence in cancer patients: trial protocol for a multisite randomised controlled trial. BMJ Open 2021, 11: e051226. PMID: 34187835, PMCID: PMC8245459, DOI: 10.1136/bmjopen-2021-051226.Peer-Reviewed Original ResearchMeSH KeywordsHumansMotivationNeoplasmsRandomized Controlled Trials as TopicSmokingSmoking CessationTobacco Use Cessation DevicesConceptsSmoking abstinenceSelf-reported smoking abstinenceCancer-specific mortalityNicotine replacement therapyTime of surgeryDay of surgerySmoking cessation treatmentCancer treatment toxicitiesSouth Carolina Institutional Review BoardEffect of CMBreath carbon monoxideContingency management interventionCO breath testInstitutional review boardSubstantial health risksOperable cancerContinued smokingPeer-reviewed journalsPreoperative periodStandard careSurgical complicationsTreatment toxicitySecondary malignanciesCessation treatmentReplacement therapyThe effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials
Haeny AM, Gueorguieva R, Montgomery L, Bold KW, Fucito LM, Wu R, Muvvala SB, Zweben A, O'Malley SS. The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials. Addictive Behaviors 2021, 122: 106970. PMID: 34216871, PMCID: PMC9426655, DOI: 10.1016/j.addbeh.2021.106970.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcoholismCigarette SmokingDouble-Blind MethodFemaleHumansMaleSmokingSmoking CessationTreatment OutcomeVareniclineConceptsEffects of vareniclineAlcohol use disorderCigarette smokingClinical trialsUse disordersWhite adultsEfficacy of vareniclineNumber of drinksVareniclineSmokingPrimary analysisAlcohol treatmentSecondary analysisAlcohol useTrialsBlack participantsDrinking outcomesLinear mixed modelsAdultsWhite peopleWhite participantsMixed modelingCigarettesDisordersTreatmentClearing the Haze: What Do We Still Need to Learn about Electronic Nicotine Delivery Systems?
Fucito LM, Malinosky H, Baldassarri SR, Herbst RS. Clearing the Haze: What Do We Still Need to Learn about Electronic Nicotine Delivery Systems? Cancer Prevention Research 2021, 14: 5-10. PMID: 33148678, PMCID: PMC8324047, DOI: 10.1158/1940-6207.capr-20-0394.Peer-Reviewed Original Research
2020
A Preoperative Contingency Management Intervention for Smoking Abstinence in Cancer Patients: A Preliminary Randomized Controlled Trial
Rojewski AM, Fucito LM, Baker NL, Krishnan-Sarin S, Carpenter MJ, Bernstein SL, Toll BA. A Preoperative Contingency Management Intervention for Smoking Abstinence in Cancer Patients: A Preliminary Randomized Controlled Trial. Nicotine & Tobacco Research 2020, 23: 1064-1067. PMID: 33340400, PMCID: PMC8248947, DOI: 10.1093/ntr/ntaa266.Peer-Reviewed Original ResearchMeSH KeywordsBehavior TherapyFemaleHumansMaleMiddle AgedMotivationNeoplasmsPreoperative PeriodSmokingSmoking CessationTobacco Use Cessation DevicesConceptsDay of surgeryCancer surgeryAbstinence ratesContingency management interventionCM patientsCM interventionSeven-day point prevalence abstinence ratesCM groupSelf-reported smoking abstinencePoint prevalence abstinence ratesTobacco treatment programEnd of treatmentIncentives contingentMonetary incentives contingentBreath carbon monoxideCO breath testMultisite pilot studyOperable cancerStandard careNicotine patchCancer patientsSmoking abstinenceSurgical proceduresBreath testPatientsImpact of the COVID‐19 pandemic on telehealth research in cancer prevention and care: A call to sustain telehealth advances
Park ER, Chiles C, Cinciripini PM, Foley KL, Fucito LM, Haas JS, Joseph AM, Ostroff JS, Rigotti NA, Shelley DR, Taylor KL, Zeliadt SB, Toll BA, Group T. Impact of the COVID‐19 pandemic on telehealth research in cancer prevention and care: A call to sustain telehealth advances. Cancer 2020, 127: 334-338. PMID: 33048350, PMCID: PMC7675475, DOI: 10.1002/cncr.33227.Peer-Reviewed Original ResearchPragmatic Application of the RE-AIM Framework to Evaluate the Implementation of Tobacco Cessation Programs Within NCI-Designated Cancer Centers
D'Angelo H, Ramsey AT, Rolland B, Chen LS, Bernstein SL, Fucito LM, Hooper M, Adsit R, Pauk D, Rosenblum MS, Cinciripini PM, Joseph A, Ostroff JS, Warren GW, Fiore MC, Baker TB. Pragmatic Application of the RE-AIM Framework to Evaluate the Implementation of Tobacco Cessation Programs Within NCI-Designated Cancer Centers. Frontiers In Public Health 2020, 8: 221. PMID: 32596200, PMCID: PMC7304341, DOI: 10.3389/fpubh.2020.00221.Peer-Reviewed Original ResearchMeSH KeywordsHumansNational Cancer Institute (U.S.)NeoplasmsSmokersSmoking CessationTobacco Use CessationTobacco Use DisorderUnited StatesConceptsTobacco treatment servicesCancer care settingsNational Cancer InstituteRE-AIM frameworkCancer CenterCare settingsTreatment servicesElectronic health recordsCessation servicesCessation outcomesCancer Center Cessation InitiativeCessation service deliveryDelivery of tobaccoPatients' tobacco useTobacco treatment programTobacco cessation programBetter patient outcomesCurrent smokersCessation initiativesTobacco treatmentTobacco cessationPatient populationCessation programsTreatment referralPatient outcomes
2019
Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking
Bold KW, Zweben A, Fucito LM, Piepmeier ME, Muvvala S, Wu R, Gueorguieva R, O'Malley SS. Longitudinal Findings from a Randomized Clinical Trial of Varenicline for Alcohol Use Disorder with Comorbid Cigarette Smoking. Alcohol Clinical And Experimental Research 2019, 43: 937-944. PMID: 30817018, PMCID: PMC7039307, DOI: 10.1111/acer.13994.Peer-Reviewed Original ResearchConceptsEnd of treatmentAlcohol use disorderHeavy drinking daysMedical managementCigarette smokingComorbid cigarette smokingUse disordersDrinking daysCo-occurring alcohol use disorderHigh ratePlacebo-controlled trialBetter clinical outcomesAssessment of alcoholPercent of participantsVarenicline treatmentClinical outcomesSmoking abstinenceParallel groupClinical trialsTimeline FollowVareniclineSmoking behaviorAlcohol treatmentPosttreatment outcomesMultisite trial
2018
A Pilot Clinical Trial of Smoking Cessation Services Implemented in the Workplace for Service Industry Employees
Bold KW, Kimmel L, Hanrahan TH, Romano D, Rojewski AM, Krishnan-Sarin S, Fucito LM, O’Malley S. A Pilot Clinical Trial of Smoking Cessation Services Implemented in the Workplace for Service Industry Employees. American Journal Of Health Promotion 2018, 33: 516-524. PMID: 30153737, PMCID: PMC7259449, DOI: 10.1177/0890117118795987.Peer-Reviewed Original ResearchConceptsSmoking cessation servicesService industry employeesCessation servicesQuit attemptsIndustry employeesEvidence-based tobacco treatmentPilot clinical trialEnd of treatmentFree pharmacotherapyTobacco treatmentPreliminary efficacyHelpful overallClinical trialsSmoking treatmentSuccessful abstinenceContingency managementEmployeesIndividual counselingTreatmentStatus SurveyPrimary measureService settingsHigh rateWorkplaceAbstinenceEffect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial
O’Malley S, Zweben A, Fucito LM, Wu R, Piepmeier ME, Ockert DM, Bold KW, Petrakis I, Muvvala S, Jatlow P, Gueorguieva R. Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial. JAMA Psychiatry 2018, 75: 129-138. PMID: 29261824, PMCID: PMC5838706, DOI: 10.1001/jamapsychiatry.2017.3544.Peer-Reviewed Original ResearchConceptsAlcohol use disorderMedical managementUse disordersCigarette smokingWeek 9Varenicline tartrateEfficacy of vareniclinePlacebo-controlled trialBehavioral health risksComorbid cigarette smokingRace/ethnicityAlcohol dependence criteriaSmoking 2Medication adherenceOutpatient clinicPlacebo pillsMean ageEligible participantsSmoking abstinenceClinical trialsParallel groupPlaceboMAIN OUTCOMEVareniclineWeek 13
2017
Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: A pilot study
Baldassarri SR, Bernstein SL, Chupp GL, Slade MD, Fucito LM, Toll BA. Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: A pilot study. Addictive Behaviors 2017, 80: 1-5. PMID: 29304395, PMCID: PMC6463885, DOI: 10.1016/j.addbeh.2017.11.033.Peer-Reviewed Original ResearchConceptsTobacco treatment programTreatment-seeking smokersElectronic cigarettesWeek 24Tobacco treatmentTobacco smokersTreatment programTobacco treatment interventionsTobacco smokingPatch therapyTobacco dependenceEffective adjunctBehavioral counselingMean reductionSmokersSmoking outcomesTreatment settingsTreatment interventionsSmokingNicotine solutionPilot studyNicotineCigarettesSignificant differencesSubjectsThe clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial
Zweben A, Piepmeier M, Fucito L, O'Malley S. The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial. Journal Of Substance Use And Addiction Treatment 2017, 77: 72-78. PMID: 28476276, PMCID: PMC5480370, DOI: 10.1016/j.jsat.2017.04.001.Peer-Reviewed Original ResearchConceptsMedication Adherence QuestionnaireMedication adherenceAdherence QuestionnaireMedical managementTreatment attendanceAlcohol pharmacotherapy trialsAlcohol-dependent smokersTreatment satisfaction ratingsBrief psychosocial treatmentsAlcohol use disorderMM sessionsPharmacology treatmentBaseline characteristicsBaseline demographicsAlcohol pharmacotherapyMedication nonadherenceUnintentional nonadherenceAdherence groupPharmacotherapy trialsDependent smokersTreatment adherenceSingle administrationPatient ratingsTreatment periodClinical utility
2016
Pairing smoking‐cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco
Fucito LM, Czabafy S, Hendricks PS, Kotsen C, Richardson D, Toll BA, Committee F. Pairing smoking‐cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer 2016, 122: 1150-1159. PMID: 26916412, PMCID: PMC4828323, DOI: 10.1002/cncr.29926.Peer-Reviewed Original ResearchConceptsLung cancer screeningSmoking cessation interventionUS Preventive Services Task ForceLow-dose computed tomographyCancer screeningSmoking cessationTobacco useEvidence-based smoking cessation interventionsAge 55Evidence-based smoking cessation treatmentLung cancer screening participantsAnnual lung cancerPatients age 55Pack-year historySmoking cessation effortsSmoking cessation servicesSmoking cessation treatmentHigh-risk groupEvidence-based treatmentsEvidence-based behavioral strategiesScreening participantsLung cancerClinical guidelinesClinical recommendationsPremature mortality
2015
Heavy-Drinking Smokers' Treatment Needs and Preferences: A Mixed-Methods Study
Fucito LM, Hanrahan TH. Heavy-Drinking Smokers' Treatment Needs and Preferences: A Mixed-Methods Study. Journal Of Substance Use And Addiction Treatment 2015, 59: 38-44. PMID: 26297324, PMCID: PMC4548819, DOI: 10.1016/j.jsat.2015.07.001.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcohol DrinkingFemaleHumansMaleMiddle AgedPatient PreferenceQualitative ResearchSmokingSmoking CessationSmoking PreventionConceptsAlcohol interventionsHeavy drinking smokersMixed-methods studyPerceptions of smokingSmoking cessationTreatment preferencesSmokingStress/negative affectHealth gainsHealth feedbackTreatment formatStrong associationSemi-structured focus group interviewsTreatment modelSmokersOverall enthusiasmDrinkingBehavior changeInterventionGreatest barrierMethods studyTreatmentStandardized surveyFocus group interviewsParticipantsA Randomized Trial for Hazardous Drinking and Smoking Cessation for Callers to a Quitline
Toll BA, Martino S, O’Malley S, Fucito LM, McKee SA, Kahler CW, Rojewski AM, Mahoney MC, Wu R, Celestino P, Seshadri S, Koutsky J, Hyland A, Cummings KM. A Randomized Trial for Hazardous Drinking and Smoking Cessation for Callers to a Quitline. Journal Of Consulting And Clinical Psychology 2015, 83: 445-454. PMID: 25419583, PMCID: PMC5996380, DOI: 10.1037/a0038183.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcoholismCounselingFemaleHotlinesHumansMaleMiddle AgedNew YorkSmokingSmoking CessationTobacco Use DisorderTreatment OutcomeConceptsStandard careHazardous drinkingHigher smoking cessation ratesNew York State Smokers' QuitlineHeavy drinkingBrief motivational counselingSmoking cessation ratesState Smokers' QuitlineBrief alcohol interventionTelephone coachesCessation counselingTreat analysisCessation ratesRandomized trialsTelephone quitlinesCessation successSmoking cessationAcceptable adherenceMotivational counselingQuitlineAlcohol interventionsAlcohol useCareSmokersDrinking
2014
Addressing the Evidence for FDA Nicotine Replacement Therapy Label Changes: A Policy Statement of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco
Fucito LM, Bars MP, Forray A, Rojewski AM, Shiffman S, Selby P, West R, Foulds J, Toll BA, Networks W. Addressing the Evidence for FDA Nicotine Replacement Therapy Label Changes: A Policy Statement of the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Nicotine & Tobacco Research 2014, 16: 909-914. PMID: 24919399, PMCID: PMC6281057, DOI: 10.1093/ntr/ntu087.Peer-Reviewed Original ResearchConceptsQuit attemptsQuit dateSmoking reductionEffective smoking cessation interventionsSubstantial public health burdenAid smoking cessationNicotine patch useSmoking cessation interventionPublic health burdenShort-acting formsNRT formulationsNRT medicationsRecalcitrant smokersNicotine patchCessation interventionsCigarette smokingSmoking cessationHealth burdenProvider consultationTobacco useDrug AdministrationRelapse preventionSmokersLabeling changesMonths“Quitting Smoking Will Benefit Your Health”: The Evolution of Clinician Messaging to Encourage Tobacco Cessation
Toll BA, Rojewski AM, Duncan LR, Latimer-Cheung AE, Fucito LM, Boyer JL, O'Malley SS, Salovey P, Herbst RS. “Quitting Smoking Will Benefit Your Health”: The Evolution of Clinician Messaging to Encourage Tobacco Cessation. Clinical Cancer Research 2014, 20: 301-309. PMID: 24436474, PMCID: PMC3927319, DOI: 10.1158/1078-0432.ccr-13-2261.Peer-Reviewed Original ResearchMeSH KeywordsHumansLung NeoplasmsPhysician's RoleSmoking CessationText MessagingTobacco Use CessationConceptsCancer-related deathHeart diseaseTobacco useLung cancer-related deathsSubgroups of smokersBurden of cancerModerators of treatmentAdult patientsCessation interventionsSmoking cessationTobacco cessationQuitting smokingPreventable deathsGain-framed messagesSmokingTobacco productsCancerDiseaseDeathPatientsLungStrokeCessationHealthFuture studies